Error-prone candidates vie for somatic mutation - PubMed (original) (raw)

Comment

Error-prone candidates vie for somatic mutation

V Poltoratsky et al. J Exp Med. 2000.

No abstract available

PubMed Disclaimer

Figures

Figure 1

Figure 1

A speculative mechanism for somatic V region hypermutation. I. An unusual cytidine deaminase might play a role in the introduction of abasic lesions (O) in DNA via conversion of C to U, followed by the removal of the U by uracil glycosylase (UDG1). RGYW/WRCY represent a hot spot template sequence (A/G, G, C/T, A/T), with a mutation occurring most frequently opposite the G/C. II. A high-fidelity processive replicative polymerase (pol δ) stalls at the abasic lesion, dissociates, and is replaced by a promiscuous nonprocessive polymerase, e.g., pol ι (shown in sketch), or by some other errant polymerase. After translesional synthesis resulting in a mutation opposite the lesion, pol ι dissociates, and processive synthesis resumes with pol δ. III. A subsequent round of replication results in a mixed population of B cell clones, some mutated and some not. Alternative mechanisms can be envisioned that do not involve the introduction of a lesion. Instead, an undamaged DNA template could be copied by a low-fidelity polymerase such as pol ι, causing mutations that are favored in the RGYW hot spot sequence.

Comment on

Similar articles

Cited by

References

    1. Harris R.S., Kong Q., Maizels N. Somatic hypermutation and the three R'srepair, replication and recombination. Mutat. Res. 1999;436:157–178. - PubMed
    1. Steele E.J., Rothenfluh H.S., Blanden R.V. Mechanism of antigen-driven somatic hypermutation of rearranged immunoglobulin V(D)J genes in the mouse. Immunol. Cell Biol. 1997;75:82–95. - PubMed
    1. Wilson P., Liu Y.J., Banchereau J., Capra J.D., Pascual V. Amino acid insertions and deletions contribute to diversify the human Ig repertoire. Immunol. Rev. 1998;162:143–151. - PubMed
    1. Milstein C., Neuberger M.S., Staden R. Both DNA strands of antibody genes are hypermutation targets. Proc. Natl. Acad. Sci. USA. 1998;95:8791–8794. - PMC - PubMed
    1. Jolly C.J., Wagner S.D., Rada C., Klix N., Milstein C., Neuberger M.S. The targeting of somatic hypermutation. Semin. Immunol. 1996;8:159–168. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources